LIF and breast cancer: Different clinical subtypes of breast cancer vary in their immunological characteristics, comprising of tumor-infiltrating lymphocytes (TILs CD4, CD8), expression of programmed death ligand-1 (PD-L1), leukemia inhibitory factor (LIF), tumor-associated antigen, and random gene mutations (6).